PETS vs CVS
Head-to-Head Stock Analysis & Investment Rating
Last Updated: Nov 13, 2026
PETS
CVS
Investment Advisor Scores
CVS
AI Analyst Insights
Detailed Metrics Comparison
| Metric | PETS | CVS | Winner |
|---|---|---|---|
|
Valuation
Lower P/E and PEG ratios suggest a stock may be undervalued relative to earnings and growth. Value investors prefer lower multiples. |
|||
| Forward P/E | 16.6945 | 10.582 | CVS |
| PEG Ratio | 2.3225 | 0.2182 | CVS |
|
Growth
Higher revenue and earnings growth rates indicate a company is expanding faster. Strong growth often justifies premium valuations. |
|||
| Revenue Growth | -19.4% | 5.4% | CVS |
| Earnings Growth | 266.7% | 188.8% | PETS |
|
Quality & Profitability
Higher Tradestie Score and profit margins reveal how efficiently a company operates. Strong profitability indicates competitive advantages. |
|||
| Tradestie Score | 38.5/100 | 59.5/100 | CVS |
| Profit Margin | -17.0% | 2.6% | CVS |
|
Risk Profile
Lower Beta and Implied Volatility values indicate reduced market risk. Conservative investors favor stocks with less price volatility. |
|||
| Beta | 1.00 | 1.00 | Tie |
|
Sentiment
AI Recommendation reflects overall analyst and proprietary sentiment. Stronger recommendations signal higher conviction. |
|||
| AI Recommendation | AVOID NEW MONEY | BUY | CVS |
Relative Price Performance (Last 90 Days)
Current Technical Phase
PETS
MarkdownPrice below a falling SMA50 (slope -16.9%), weak momentum, RSI 21
CVS
NeutralMixed signals - no dominant trend phase, RSI 51
Fundamentals Snapshot
| Metric | PETS | CVS |
|---|---|---|
| Market Cap | — | — |
| Forward P/E | 13.4 | 10.3 |
| Trailing P/E | — | 10.4 |
| Revenue (TTM) | — | — |
| Revenue Growth | -0.2% | 0.1% |
| Gross Margin | 0.3% | 0.1% |
| Operating Margin | -0.2% | 0.0% |
| EPS | -1.20 | 8.61 |
| Dividend Yield | — | 0.03% |